Icu Medical (ICUI) Cash from Financing Activities (2009 - 2026)
Icu Medical's (ICUI) quarterly Cash from Financing Activities came in at -$50.2 million in Q2 2026, up 74.24% on a YoY basis from -$28.8 million in Q2 2025, and down 13.85% quarter-over-quarter from -$44.1 million in Q1 2026.
Analysis
Icu Medical (ICUI) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Icu Medical (ICUI) has reported Cash from Financing Activities for 18 consecutive years, with -$50.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities rose 74.24% year-over-year to -$50.2 million; the trailing twelve-month figure through Jun 2026 stood at -$154.5 million (up 42.75% YoY), and the FY2025 full-year result was -$311.5 million, down 458.29% from the prior year.
- Cash from Financing Activities slipped to -$50.2 million in Q2 2026 per ICUI's latest filing, from -$44.1 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $1.6 billion in Q1 2022 and bottomed at -$195.0 million in Q2 2025.
- Historically, Cash from Financing Activities has averaged $63.3 million across 5 years, with a median of -$10.4 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities jumped 55063.9% in 2022, then slumped 1778.03% in 2025.
- Over 5 years, Cash from Financing Activities stood at -$10.4 million in 2022, then gained by 24.42% to -$7.8 million in 2023, then decreased by 4.36% to -$8.2 million in 2024, then sank by 321.01% to -$34.5 million in 2025, then slumped by 45.67% to -$50.2 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$50.2 million, -$44.1 million, and -$34.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | -343.00 Mn |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | -95.00 Mn |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | -410.00 Mn |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | -300,000.00 |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | -607.30 Mn |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | -263.16 Mn |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | -510.00 Mn |
| 10 | Icu Medical | 3.82 Bn | 3.52 Bn | 235.05 Mn | -50.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -50.24 Mn |
| Mar 31, 2026 | -44.12 Mn |
| Dec 31, 2025 | -34.49 Mn |
| Sep 30, 2025 | -25.69 Mn |
| Jun 30, 2025 | -195.02 Mn |
| Mar 31, 2025 | -56.34 Mn |
| Dec 31, 2024 | -8.19 Mn |
| Sep 30, 2024 | -10.38 Mn |
| Jun 30, 2024 | -10.38 Mn |
| Mar 31, 2024 | -26.85 Mn |
| Dec 31, 2023 | -7.85 Mn |
| Sep 30, 2023 | -6.40 Mn |
| Jun 30, 2023 | -5.90 Mn |
| Mar 31, 2023 | -15.84 Mn |
| Dec 31, 2022 | -10.39 Mn |
| Sep 30, 2022 | 2.53 Mn |
| Jun 30, 2022 | -4.03 Mn |
| Mar 31, 2022 | 1.65 Bn |
| Dec 31, 2021 | -15.28 Mn |
| Sep 30, 2021 | 1.11 Mn |